Classical: PianoArts Festival Features Rising Stars
Young competition winners and skilled veterans perform in North American event.
Source: urbanmilwaukee.com
📰 Peter Tak News
Peter Tak News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Tak. Real-time updates on events, politics, business and more.
GSK's New Vaccine Kept the Boss in Her Job — and an Activist at Bay
(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyIran State TV Says ‘No Sign of Life’ at Helicopter Crash SiteJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’One of the Last Big Bears on Wall Street Turns Bullish on US StocksFlori...
Source: yahoo.com
CAN-2409 Receives FDA Orphan Drug Designation in Pancreatic Cancer
CAN-2409 has received orphan drug designation from the FDA for the treatment of patients with pancreatic cancer.
Garrett Nichols Candel Therapeutics Inc Candel Therapeutics Peter Tak Gastrointestinal Cancer Metastatic Pancreatic Ductal Adenocarcinoma
Source: onclive.com
CAN-2409 Plus Valacyclovir Generates Positive Phase 2 Survival Results in PDAC
Positive phase 2 findings for CAN-2409 plus valacyclovir in pancreatic ductal adenocarcinoma have been reported.
Source: onclive.com
FDA Grants Fast Track Designation to CAN-3110 for Recurrent High-Grade Glioma
CAN-3110, an HSV-1 oncolytic viral immunotherapy candidate, has received FDA fast track designation for adult patients with recurrent high-grade glioma.
United States Antonio Chiocca Harvard Medical School Department Of Neurosurgery At Brigham Peter Tak Candel Therapeutics
Source: onclive.com
FDA Grants Fast Track Status to Aglatimagene Besadenovec Plus Valacyclovir for Pancreatic Cancer
The FDA has granted fast track designation to aglatimagene besadenovec plus valacyclovir for use as a potential therapeutic option in patients with pancreatic ductal adenocarcinoma.
Candel Therapeutics Inc Candel Therapeutics Peter Tak Fast Track Designation To Aglatimagene Besadenovec Plus Valacyclovir Patients With Pancreatic Ductal Adenocarcinoma Paul Peter Tak
Source: onclive.com
Candel Therapeutics Presents Preclinical Data from its enLIGHTEN™ Discovery Platform at SITC
The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate innate immune surveillanceApplication of the...
Source: marketscreener.com
Candel Therapeutics : Shareholder Director Nominations - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT ... | May 9, 2023
United States Candel Therapeutics Inc Securities Exchange Exchange Commission Commission File Number Securities Exchange Act
Source: marketscreener.com
Citryll Announces the Appointment of Paul Peter Tak as Chair of the Board of Directors
Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat autoimmune and autoinflammatory diseases, today announced that Dr. Paul Peter Tak, Citryll Board member since
Source: finanznachrichten.de
Urban Milwaukee » » Michael Barndt
Performing Argentine tango music with cellist Roza Borisova on March 27.
Source: urbanmilwaukee.com